Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.
Aug 2009 - J. Clin. Immunol.; 29(5):1573-2592 [PMID:19421847]
[Cornforth AN] [Lee GJ] [Fowler AW] [Carbonell DJ] [Dillman RO]

Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells.
May 2008 - Cancer Biother. Radiopharm.; 23(2):1557-8852 [PMID:18454690]
[Schiltz PM] [Dillman RO] [Korse CM] [Cubellis JM] [Lee GJ] [De Gast GC]